Recent Finacing
Recent Raise
OnQuality Pharmaceuticals develops targeted supportive-care therapies for oncology—topical OQL011 in U.S. Phase II for hand-foot skin reaction, OQL023/OQL033 in IND-enabling, with R&D in Seattle and Shanghai.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
